NCT03222427 - A Study of LY3314814 in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

February 16, 2018

Study Completion Date

February 16, 2018

Conditions

Healthy

Interventions

DRUG

LY3314814

Administered orally

DRUG

[13C415N3] LY3314814

Administered as an IV infusion

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds